XML 58 R42.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Collaboration Agreements (Royalty Revenues under the Collaboration Agreement with GSK) (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Dec. 29, 2017
Collaborative Arrangements with Glaxo Smith Kline      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Royalty expense $ 31.3 $ 24.0 $ 12.4
Collaborative Arrangement with GlaxoSmithKline      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Collaboration agreement percent of royalty on net sale 3.00%